Cardia secures seven new patents

Cardia Bioplastics secured seven new patents in 2014 for its Cardia Compostable, Biohybrid and PPC-starch resin and finished products from Patent and Trademark Offices in Japan, Australia, New Zealand and China.

This brings the number of patents granted to the company to 19. Cardia has had patents granted in the US, Australia, China, Japan, New Zealand and South Africa.

“This marks an important milestone for Cardia Bioplastics. These granted patents protect the intellectual property of the company and further support the technical differentiation of our globally certified Cardia Compostable and independently validated lower carbon footprint Cardia Biohybrid product offering,” said Dr Frank Glatz, managing director of Cardia Bioplastics.

“Cardia is collaborating with leading global brand owners to reduce the environmental impact of their packaging. Cardia’s Biohybrid technology enables them to reduce the carbon footprint and the use of less oil in their packaging with an environmental benefit whilst maintaining product performance. Cardia’s strong patent position and freedom to operate is a critical requirement for these large global brand owners.”